Stay updated on Safety & Efficacy of Dupilumab in Young Children Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of Dupilumab in Young Children Clinical Trial page.

Latest updates to the Safety & Efficacy of Dupilumab in Young Children Clinical Trial page
- Check4 days agoChange DetectedAdded a full citation for the 2026 Paediatr Drugs article on dupilumab in children aged 6 months to 5 years to the Publications section, now dated May 2026. Removed the earlier 'Online ahead of print' entry with April 2026 date, updating the Publications section to reflect the finalized bibliographic record.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s footer “Revision” version was updated from v3.5.2 to v3.5.3, reflecting a maintenance/versioning change rather than any change to the clinical trial study information.SummaryDifference0.0%

- Check26 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check33 days agoChange DetectedPublication added: a new citation is listed under Publications for Long-Term Safety and Efficacy of Dupilumab in children aged 6 months to 5 years with severe atopic dermatitis (Paediatr Drugs, 2026 Apr 2).SummaryDifference0.0%

- Check56 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check63 days agoChange DetectedPage revision updated to v3.4.3; v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to Safety & Efficacy of Dupilumab in Young Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of Dupilumab in Young Children Clinical Trial page.